Bioverativ
| Use attributes for filter ! | |
| Ceo | John G. Cox |
|---|---|
| Parent organizations | Sanofi |
| Number of employees | 400 |
| Founded | 2016 |
| Traded as | NASDAQ |
| Subsidiaries | True North Therapeutics, Inc. |
| Bioverativ Therapeutics Inc. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 942349 |
About Bioverativ
Bioverativ Inc. is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia. Bioverativ competes with Baxalta, Pfizer and Novo Nordisk.
